CIK 0000863894
- Non-accelerated filer
- Smaller reporting company
VERU INC.
Sign in to watch- Ticker
- VERU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- WI
- Entity type
- Operating
- EIN
- 391144397
- Phone
- +1 312-595-9123
- Business address
- 2916 N. MIAMI AVENUE, SUITE 1000, MIAMI, FL, 33127
- Former names
- FEMALE HEALTH CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-08 | STEINER MITCHELL SHUSTER President and CEO | Sale | −6,955 | $1.50 | $10K | 7,724,312 |
| 2019-02-07 | STEINER MITCHELL SHUSTER President and CEO | Sale | −300 | $1.50 | $450 | 7,731,267 |
| 2019-02-06 | STEINER MITCHELL SHUSTER President and CEO | Sale | −3,200 | $1.51 | $5K | 7,731,567 |
| 2019-01-24 | STEINER MITCHELL SHUSTER President and CEO | Sale | −4,400 | $1.33 | $6K | 7,734,767 |
| 2019-01-23 | STEINER MITCHELL SHUSTER President and CEO | Sale | −12,768 | $1.34 | $17K | 7,739,167 |
| 2019-01-18 | STEINER MITCHELL SHUSTER President and CEO | Sale | −12,832 | $1.34 | $17K | 7,751,935 |
| 2019-01-02 | Todd Charles T Jr CEO of FHC Division | Grant or award · Common Stock Option | +42,226 | 42,226 | ||
| 2018-12-18 | FISCH HARRY Director | Purchase | +30,000 | $1.42 | $43K | 781,944 |
| 2018-12-18 | BARNETTE K GARY Chief Scientific Officer | Purchase | +50,000 | $1.51 | $76K | 100,000 |
| 2018-12-17 | BARNETTE K GARY Chief Scientific Officer | Purchase | +50,000 | $1.41 | $71K | 50,000 |
| 2018-12-11 | STEINER MITCHELL SHUSTER President and CEO | Grant or award · Common Stock Option | +125,802 | 125,802 | ||
| 2018-12-11 | Greco Michele Chief Admin Officer & CFO | Grant or award · Common Stock Option | +83,025 | 83,025 | ||
| 2018-12-11 | FISCH HARRY Director | Grant or award · Common Stock Option | +37,395 | 37,395 | ||
| 2018-10-31 | BETHUNE DAVID R Director | Exercise or conversion | +140,000 | 575,982 | ||
| 2018-10-31 | BETHUNE DAVID R Director | Exercise or conversion · Restricted Stock Units | −140,000 | 0 | ||
| 2018-09-06 | FISCH HARRY Director | Purchase | +8,000 | $1.88 | $15K | 751,944 |
| 2018-09-06 | Socorro Jesus Director | Purchase | +5,400 | $1.89 | $10K | 12,500 |
| 2018-09-05 | FISCH HARRY Director | Purchase | +7,800 | $1.91 | $15K | 743,944 |
| 2018-09-04 | BARNETTE K GARY Chief Scientific Officer | Grant or award · Common Stock Option | +300,000 | 300,000 | ||
| 2018-08-17 | Rankowitz Michael L Director | Grant or award · Common Stock Option | +5,000 | 5,000 |
Page 10 of 14 · 264 trades